Literature DB >> 23818005

Correlation between glycemic control and the incidence of peritoneal and catheter tunnel and exit-site infections in diabetic patients undergoing peritoneal dialysis.

Ana Rodríguez-Carmona1, Miguel Pérez-Fontán1, Andrés López-Muñiz1, Tamara Ferreiro-Hermida1, Teresa García-Falcón1.   

Abstract

BACKGROUND: Diabetes mellitus, especially if complicated by poor glycemic control, portends an increased risk of infection. The significance of this association in the case of diabetic patients undergoing peritoneal dialysis (PD) has not been assessed.
METHODS: Using a retrospective observational design, we analyzed the association between glycemic control at the start of PD (estimated from glycosylated hemoglobin levels) and the risk of peritoneal and catheter tunnel and exit-site infections during follow-up in 183 incident patients on PD. We used the median value of glycosylated hemoglobin to classify patients into good (group A) or poor (group B) glycemic control groups. We applied multivariate strategies of analysis to control for other potential predictors of PD-related infection.
RESULTS: Groups A and B differed significantly in age, dialysis vintage, use of insulin, and rate of Staphylococcus aureus carriage. Neither the incidence (0.60 episodes in group A vs 0.56 episodes in group B per patient-year) nor the time to a first peritoneal infection (median: 42 months vs 38 months) differed significantly between the study groups. In contrast, group B had a significantly higher incidence of catheter tunnel and exit-site infections (0.23 episodes vs 0.12 episodes per patient-year) and shorter time to a first infection episode (64 months vs 76 months, p = 0.004). The difference persisted in multivariate analysis (adjusted hazard ratio: 2.65; 95% confidence interval: 1.13 to 6.05; p = 0.013). We observed no differences between the study groups in the spectrum of causative organisms or in the outcomes of PD-related infections.
CONCLUSIONS: Poor glycemic control is a consistent predictor of subsequent risk of catheter tunnel and exit-site infection, but not of peritoneal infection, among diabetic patients starting PD therapy.
Copyright © 2014 International Society for Peritoneal Dialysis.

Entities:  

Keywords:  Peritonitis; catheter tunnel infection; diabetes; exit-site infection; glycosylated hemoglobin; hyperglycemia

Mesh:

Substances:

Year:  2013        PMID: 23818005      PMCID: PMC4164406          DOI: 10.3747/PDI.2012.00185

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  24 in total

Review 1.  The treatment of diabetic end-stage renal disease with peritoneal dialysis.

Authors:  M Feriani; R Dell'Aquila; G La Greca
Journal:  Nephrol Dial Transplant       Date:  1998       Impact factor: 5.992

2.  A comparative analysis on the incidence of peritonitis and exit-site infection in CAPD and automated peritoneal dialysis.

Authors:  A Rodríguez-Carmona; M Pérez Fontán; T García Falcón; C Fernández Rivera; F Valdés
Journal:  Perit Dial Int       Date:  1999 May-Jun       Impact factor: 1.756

Review 3.  Common infections in diabetes: pathogenesis, management and relationship to glycaemic control.

Authors:  Anton Y Peleg; Thilak Weerarathna; James S McCarthy; Timothy M E Davis
Journal:  Diabetes Metab Res Rev       Date:  2007-01       Impact factor: 4.876

4.  A comparison of peritonitis rates from the United States Renal Data System database: CAPD versus continuous cycling peritoneal dialysis patients.

Authors:  Than N Oo; Tricia L Roberts; Allan J Collins
Journal:  Am J Kidney Dis       Date:  2005-02       Impact factor: 8.860

5.  Pre-dialysis glycemic control is an independent predictor of mortality in type II diabetic patients on continuous ambulatory peritoneal dialysis.

Authors:  M S Wu; C C Yu; C H Wu; J Y Haung; M L Leu; C C Huang
Journal:  Perit Dial Int       Date:  1999       Impact factor: 1.756

6.  A risk analysis of continuous ambulatory peritoneal dialysis-related peritonitis.

Authors:  Kai Ming Chow; Cheuk Chun Szeto; Chi Bon Leung; Bonnie Ching-Ha Kwan; Man Ching Law; Philip Kam-Tao Li
Journal:  Perit Dial Int       Date:  2005 Jul-Aug       Impact factor: 1.756

7.  Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis.

Authors:  Miguel Pérez Fontan; Ana Rodríguez-Carmona; Rafael García-Naveiro; Miguel Rosales; Pedro Villaverde; Francisco Valdés
Journal:  Perit Dial Int       Date:  2005 May-Jun       Impact factor: 1.756

Review 8.  Prognostic factors for peritonitis outcome.

Authors:  Sadie van Esch; Raymond T Krediet; Dirk G Struijk
Journal:  Contrib Nephrol       Date:  2012-05-25       Impact factor: 1.580

9.  Quantifying the risk of infectious diseases for people with diabetes.

Authors:  Baiju R Shah; Janet E Hux
Journal:  Diabetes Care       Date:  2003-02       Impact factor: 19.112

Review 10.  Diabetes, hyperglycemia, and infections.

Authors:  Ashley M Shilling; Jacob Raphael
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2008-09
View more
  3 in total

1.  Identification of Targets for Prevention of Peritoneal Catheter Tunnel and Exit-Site Infections in Low Incidence Settings.

Authors:  Clara Santos; Miguel Pérez-Fontán; Ana Rodríguez-Carmona; María Calvo-Rodríguez; Andrés López-Muñiz; Beatriz López-Calviño; Teresa García-Falcón
Journal:  Perit Dial Int       Date:  2014-10-07       Impact factor: 1.756

2.  The association between diabetes coexisting with low levels of high-density lipoprotein cholesterol and peritoneal dialysis-related peritonitis.

Authors:  Rui Zhang; Xing Zhang; Xingming Tang; Liwen Tang; Sijia Shang; Xiaoyang Wang; Yueqiang Wen; Xiaoran Feng; Qian Zhou; Ning Su; Yajuan Huang
Journal:  Diabetol Metab Syndr       Date:  2022-04-29       Impact factor: 5.395

3.  Effect of diabetes on incidence of peritoneal dialysis-associated peritonitis.

Authors:  Risa Ueda; Masatsugu Nakao; Yukio Maruyama; Akio Nakashima; Izumi Yamamoto; Nanae Matsuo; Yudo Tanno; Ichiro Ohkido; Masato Ikeda; Hiroyasu Yamamoto; Keitaro Yokoyama; Takashi Yokoo
Journal:  PLoS One       Date:  2019-12-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.